Analystreport

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at SVB Leerink LLC from $30.00 to $41.00. They now have an "outperform" rating

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com